Molecular variant of hairy cell leukemia with poor prognosis

Leukemia and Lymphoma

Volumn 52, Issue SUPPL. 2, 2011, Pages 99-102

  Arons, Evgeny ^a   Kreitman, Robert J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

HCL; HCLv; IGHV4 34; Immunoglobulin rearrangement; VH4 34

Indexed keywords

CLADRIBINE; IMMUNOGLOBULIN HEAVY CHAIN;

ARTICLE; CLINICAL FEATURE; GENE; GENE REARRANGEMENT; GENE SEQUENCE; HAIRY CELL LEUKEMIA; HAIRY CELL LEUKEMIA VARIANT; HUMAN; LEUKOCYTE COUNT; LEUKOPENIA; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; TREATMENT OUTCOME; TREATMENT RESPONSE; VH4 34 GENE;

CLADRIBINE; GENE REARRANGEMENT; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; LEUKEMIA, HAIRY CELL; PROGNOSIS; SEQUENCE ANALYSIS, DNA; TREATMENT OUTCOME;

EID: 79957445887     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.565841     Document Type: Article

References (15)

1. Cawley JC, Burns GF, Hayhoe FG. A chronic lymphoproliferative disorder with distinctive features: a distinct variant of hairy-cell leukaemia. Leuk Res 1980;4:547-559. (Pubitemid 11207672)
2. Matutes E, Wotherspoon A, Brito-Babapulle V, Catovsky D. The natural history and clinico-pathological features of the variant form of hairy cell leukemia. Leukemia 2001;15:184-186. (Pubitemid 32124084)
3. Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008.
4. Matutes E, Wotherspoon A, Catovsky D. The variant form of hairy-cell leukaemia. Best Pract Res Clin Haematol 2003;16: 41-56.
5. Arons E, Margulies I, Sorbara L, et al. Minimal residual disease in hairy cell leukemia patients assessed by clonespecific polymerase chain reaction. Clin Cancer Res 2006;12:2804-2811.
6. Arons E, Sunshine J, Suntum T, Kreitman RJ. Somatic hypermutation and VH gene usage in hairy cell leukemia. Br J Haematol 2006;133:504-512.
7. Martin-Jimenez P, Garcia-Sanz R, Gonzalez D, et al. Molecular characterization of complete and incomplete immunoglobulin heavy chain gene rearrangements in hairy cell leukemia. Clin Lymphoma Myeloma 2007;7:573-579.
8. Forconi F, Sozzi E, Rossi D, et al. Selective influences in the expressed immunoglobulin heavy and light chain gene repertoire in hairy cell leukemia. Haematologica 2008;93: 697-705. (Pubitemid 351669309)
9. Arons E, Suntum T, Stetler-Stevenson M, Kreitman RJ. VH4- 34\+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy. Blood 2009;114:4687-4695.
10. Murray F, Darzentas N, Hadzidimitriou A, et al. Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood 2008;111:1524-1533. (Pubitemid 351213442)
11. Brezinschek HP, Foster SJ, Brezinschek RI, Dorner T, Domiati-Saad R, Lipsky PE. Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5(\+)/IgM\+ and CD5(7)/IgM\+ B cells. J Clin Invest 1997;99:2488-2501. (Pubitemid 27227728)
12. RettigMB, Vescio RA, Cao J, et al. VH gene usage in multiple myeloma: complete absence of the VH4.21 (VH4-34) gene. Blood 1996;87:2846-2852.
13. Kreitman RJ, Wilson WH, Bergeron K, et al. Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy- resistant hairy-cell leukemia. N Engl J Med 2001;345: 241-247. (Pubitemid 32695063)
14. Kreitman RJ, Stetler-Stevenson M, Margulies I, et al. Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemia. J Clin Oncol 2009;27: 2983-2990.
15. Ravandi F, Jorgensen JL, O'Brien SM, et al. Eradication of minimal residual disease in hairy cell leukemia. Blood 2006;107:4658-4662. (Pubitemid 43882611)